SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (688)3/24/1999 3:01:00 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 2001
 
Option one, going forward...... do nothing other than stay the course..... a big mistake, IMO, while good projects are discounted throughout the sector.

Option two..... strategic merger(s).... I've suggested CORR to some, and there are several good fits.

Further options perhaps to be discussed in following post(s), including a 49% "Chiron-like" deal, linked to marketing rights for Adcons.



To: scaram(o)uche who wrote (688)3/25/1999 9:45:00 PM
From: scaram(o)uche  Read Replies (3) | Respond to of 2001
 
Title:
A PROCESS FOR INHIBITING COMPLEMENT ACTIVATION VIA THE
ALTERNATIVE PATHWAY
Publication date:
1999-03-04

Inventor(s):

GUPTA-BANSAL REKHA (US); BRUNDEN KURT R (US); PARENT JAMES B (US)
Applicant(s):
GLIATECH INC (US); GUPTA BANSAL REKHA (US); BRUNDEN KURT R (US);
PARENT JAMES B (US)
Requested Patent:
WO9910009 A 19990304
Application Number:
WO1998US17500 19980824
Priority Number(s):
US19970918349 19970826
IPC Classification:
A61K39/395 ; A61M1/36


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News